VJHemOnc

25/11/2022

Want to learn more about genomic testing & clinical decision making in ? 📣

Our latest feature has everything you need, covering the importance of genomic testing and the impact of these results on diagnosis, prognosis and guiding treatment decisions

Check it out here 👉 http://ow.ly/NnzW50J9Tr7

21/11/2022

We are hosting a Post-ASH Virtual Workshop Series, featuring presentations & discussions on selected abstracts from the 64th Annual Meeting, with leading experts 🩸💻

We will be covering:
➡️ Acute Myeloid ( )
➡️ Acute Lymphoblastic ( )
➡️ Myelodysplastic Syndromes ( )
➡️ Myeloproliferative Neoplasms ( )
➡️ Multiple ( )
➡️ & Chronic Lymphocytic ( )

Don’t miss it!

Find out more & apply to register for FREE using this link 👉 https://www.vjhemonc.com/feature/post-ash-2022-highlights/

Our VJHemOnc team will also be on site at , bringing you the latest updates & highlights during the congress so give us a follow! 🔔

American Society of Hematology

10/11/2022

NEW episode: ' Session II: Understanding and harnessing the against ' 🎧

In this exclusive podcast, you will hear from experts:
➡️ John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute
➡️ Stephen Ansell, MD, PhD, Mayo Clinic
➡️ John Kuruvilla, MD, FRCPC, Princess Margaret Cancer Centre
➡️ Gael Roue, PhD, Josep Carreras Leukemia Research Institute

They discuss the importance of understanding the immune in . They outline strategies to engage the innate and adaptive anti-tumor , and explain how this can be used to enhance the efficacy of 💡

Give it a listen here 👉 https://lnkd.in/e5sWKH6K

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space 💡

Remember to SUBSCRIBE so you don't miss any future episodes! 📱

The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in...

03/11/2022

NEW episode: 'The role of the innate immune system in ' 🎧

In this exclusive podcast, you will hear from experts:
➡️ Rafael Bejar, MD, PhD, University of California
➡️ Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center
➡️ David Sallman, MD, Moffitt Cancer Center

They discuss the role of the innate in , and further highlight the role of in this disease, as well as future therapeutic strategies💡

Give it a listen here 👉 https://lnkd.in/ekZh6cSj

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space 💡

Remember to SUBSCRIBE so you don't miss any future episodes! 📱

Join us for another VJHemOnc podcast where leading experts discuss the role of the innate immune system in myelodysplastic syndromes (MDS).

25/10/2022

Find out more about the importance of genomic testing in with expert-led insights! 📣

Our latest feature covers:

- High-risk disease
- TP53 aberrations
- The importance of testing & re-testing
& MORE!

Check it out here 👉 http://ow.ly/3Xsa50JEwRQ

21/10/2022

NEW episode covering ' : meeting highlights and recent updates in ' 🎧

In this exclusive podcast, you will hear from experts:
➡️ Shaji Kumar, MD, Mayo Clinic
➡️ Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London

Topics covered include the evolution of diagnostic approaches in light chain (AL) , advances in techniques, and the role of ( ) in the era of -based therapies💡

Give it a listen here 👉 https://bit.ly/3yZXWPW

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space 💡

Remember to SUBSCRIBE so you don't miss any future episodes! 📱


International Myeloma Society

Join us for an exclusive podcast with leading experts Shaji Kumar and Ashutosh Wechalekar, as they share their highlights from the 2022 ISA Meeting.

19/10/2022

🚨LAST CHANCE🚨 to join our EXCLUSIVE VJHemOnc webinar on 'The evolving role of in multiple ' taking place TOMORROW 📣

The webinar will feature leading experts Bruno Paiva & Ola Landgren, who will discuss the role of measurable residual disease (MRD) in multiple myeloma, commenting on:

➡️ MRD assessment techniques
➡️ The prognostic value of MRD negativity
➡️ MRD-tailored treatment
& MORE

🗓️ It will take place on Thu Oct 20th, 6:00 PM - 7:00 PM BST

REGISTER here to secure a place 👉 https://bit.ly/3DJU3lb

💡Explore cutting-edge updates in MRD by disease type, including expert interviews from major international congresses, podcasts and e-learning here: https://www.vjhemonc.com/field/mrd/

14/10/2022

NEW episode covering 'Highlights from : managing high-risk & frail patients with and the prognostic value of ' 🎧

In this exclusive podcast, you will hear from experts:
➡️ Charlotte Pawlyn BA, MBBChir, MRCP, PhD, FRCPath, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
➡️ Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, University College London Hospitals NHS Foundation Trust

They hold a fascinating discussion on the management of high-risk patients, highlighting data from several UK clinical trials💡

The experts also discuss the value of MRD and its application in clinical practice, the management of frail patients, and further comment on the recent approval of by the European Medicines Agency ( ) 💭

Give it a listen here 👉 https://www.vjhemonc.com/podcast/highlights-from-ims-2022-managing-high-risk-frail-patients-with-myeloma-and-the-prognostic-value-of-mrd/

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space 💡

Remember to SUBSCRIBE so you don't miss any future episodes! 📱


International Myeloma Society

The 19th International Myeloma Society (IMS) Annual Meeting was held in Los Angeles, CA, and brought together experts in the field,...

13/10/2022

Check out our Sessions 💬

This EXCLUSIVE discussion features leading experts Ruben Mesa, MD & Naveen Pemmaraju, MD who discuss key updates in the treatment and management of

They cover several topics, including advances in the treatment of essential ( ), vera ( ) and ( ), as well as ongoing clinical trials in the field & future outlooks💡

Give it a watch here 👉 https://lnkd.in/e6iiz9kJ

10/10/2022

Our EXCLUSIVE VJHemOnc webinar on 'The evolving role of in multiple ' is taking place NEXT WEEK 📣

The webinar will feature leading experts Bruno Paiva & Ola Landgren, who will discuss the role of measurable residual disease (MRD) in multiple myeloma, commenting on:

➡️ MRD assessment techniques
➡️ The prognostic value of MRD negativity
➡️ MRD-tailored treatment
& MORE

🗓️ It will take place on Thu Oct 20th, 6:00 PM - 7:00 PM BST

REGISTER here to secure a place & don't miss it 👉 https://bit.ly/3DJU3lb

💡Explore cutting-edge updates in MRD by disease type, including expert interviews from major international congresses, podcasts and e-learning here: https://www.vjhemonc.com/field/mrd/

06/10/2022

🚨LAST CHANCE 🚨to join us TOMORROW for an exclusive VJHemOnc ALL-focused webinar 📣

The webinar will feature expert-led roundtable discussions on current topics in acute lymphoblastic leukemia ( ) being presented at

🗓️ It will take place on Fri, Oct 7, 2022 6:00 PM - 7:00 PM BST

The iwAL meeting will cover several topics, including:
➡️ Novel treatment approaches in
➡️ the use of in clinical practice
➡️ Treating relapsed disease
➡️ The role of -T therapy
& MORE

Register here & don't miss it 👉 https://bit.ly/3K9mkD3

Featuring leading experts Sabina Chiaretti, Daniel DeAngelo, Nicholas Short, Dieter Hoelzer, Robin Foà & many more!

05/10/2022

🚨LAST CHANCE 🚨to join us TOMORROW for an exclusive VJHemOnc AML-focused webinar 📣

The webinar will feature expert-led roundtable discussions on current topics in acute myeloid leukemia ( ) being presented at

🗓️ It will take place on Thu, Oct 6, 2022 6:00 PM - 7:00 PM BST

The iwAL meeting will cover several topics, including:
➡️ Current challenges and novel treatment approaches in
➡️ The use of in clinical practice
➡️ Treating high-risk disease
➡️ Mechanisms of drug resistance
& MORE

Register here & don't miss it 👉 https://bit.ly/3Cjw6Av

Featuring leading experts Charles Craddock, Naval Daver, Andrew Wei, Marion Subklewe, David Sallman, & many more!

04/10/2022

Check out our Sessions 💬

This EXCLUSIVE session features discussions from the International Myeloma Society ( ) Annual Meeting. You'll hear from leading experts:

➡️ Heinz Ludwig, MD, Wilhelminen Cancer Research Institute
➡️ Charlotte Pawlyn, BA, MBBChir, MRCP, PhD, FRCPath, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
➡️ Claudia Stege, MD, and Sonja Zweegman, MD, PhD, Amsterdam UMC
➡️ Leif Bergsagel, MD, and Marta Chesi, PhD, Mayo Clinic

They discuss the identification and management of high-risk , the optimal management of intermediate-fit and frail patients, the role of super-enhancers in this disease & MORE 💡

Give it a watch here 👉 https://www.vjhemonc.com/event/myeloma-sessions-updates-from-ims-2022/

03/10/2022

We have 2 EXCLUSIVE VJHemOnc & focused webinars taking place THIS WEEK 📣

The webinars will feature expert-led roundtable discussions on current topics in acute myeloid leukemia ( ) & acute lymphoblastic leukemia ( ) being presented at

🗓️ The AML webinar will take place on Thu, Oct 6, 2022 6:00 PM - 7:00 PM BST - Register here 👉 https://bit.ly/3Cjw6Av

🗓️ The ALL webinar will take place on Fri, Oct 7, 2022 6:00 PM - 7:00 PM BST - Register here 👉 https://bit.ly/3K9mkD3

30/09/2022

Join us for an EXCLUSIVE VJHemOnc webinar on 'The evolving role of in multiple ' 📣

The webinar will feature leading experts Bruno Paiva & Ola Landgren, who will discuss the role of measurable residual disease (MRD) in multiple myeloma, commenting on:

➡️ MRD assessment techniques
➡️ The prognostic value of MRD negativity
➡️ MRD-tailored treatment
& MORE

🗓️ It will take place on Thu Oct 20th, 6:00 PM - 7:00 PM BST

Register here & DON'T MISS IT 👉 https://bit.ly/3DJU3lb

💡Explore cutting-edge updates in MRD by disease type, including expert interviews from major international congresses, podcasts and e-learning here: https://www.vjhemonc.com/field/mrd/

30/09/2022

Check out our NEW feature on 'Highlights from the 2022 third annual Texas Workshop' 🗞️

We cover:
➡️ TREATMENT UPDATES IN : (Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center)

➡️ TREATMENT UPDATES IN MYELOFIBROSIS: (Claire Harrison, MD, DM, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust)

➡️ TREATMENT APPROACHES FOR JAK INHIBITOR-NAÏVE PATIENTS: COMBINATION THERAPY (Andrew Kuykendall, MD, H. Lee Moffitt Cancer Center & Prithviraj Bose, MBBS, The University of Texas MD Anderson Cancer Center)

➡️ UPDATES IN VERA AND ESSENTIAL (Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center)

Read the feature in full here 👉 https://www.vjhemonc.com/feature/highlights-from-the-2022-texas-mpn-workshop/

VJHemOnc is excited to bring you the latest updates from the 2022 third annual Texas MPN Workshop, which brought together leading experts to share the most recent updates in myeloproliferative neoplasms (MPNs).

29/09/2022

NEW episode covering the ' 2022: Key highlights' 🎧

In this exclusive episode you'll hear from leading experts Amer Zeidan, MBBS, Yale University School of Medicine, Rena Buckstein, MD, FRCPC, SUNNYBROOK HEALTH CARE CENTER and Valeria Santini, MD, Università degli Studi di Firenze

They discuss:
➡️ Importance of improving clinical trial design and therapeutic options for patients
➡️ Challenges in the field
& MORE

Give it a listen here 👉 https://www.vjhemonc.com/podcast/iwmds-2022-key-highlights/

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space 💡

Remember to SUBSCRIBE so you don't miss any future episodes! 📱

Join us for another exclusive podcast with MDS experts Amer Zeidan, Rena Buckstein, and Valeria Santini, who share key highlights from the 1st International Workshop on Myelodysplastic Syndromes (iwMDS) 2022.

29/09/2022

Join us next week for an EXCLUSIVE VJHemOnc AML-focused webinar 📣

The webinar will feature expert-led roundtable discussions on current topics in acute myeloid leukemia ( ) being presented at

🗓️ It will take place on Thu, Oct 6, 2022 6:00 PM - 7:00 PM BST

The iwAL meeting will cover several topics, including:
➡️ Current challenges and novel treatment approaches in
➡️ The use of in clinical practice
➡️ Treating high-risk disease
➡️ Mechanisms of drug resistance
& MORE

Register here & don't miss it 👉 https://bit.ly/3Cjw6Av

Featuring leading experts Charles Craddock, Naval Daver, Andrew Wei, Marion Subklewe, David Sallman, & many more!

28/09/2022

Join us NEXT WEEK for an EXCLUSIVE VJHemOnc ALL-focused webinar 📣

The webinar will feature expert-led roundtable discussions on current topics in acute lymphoblastic leukemia ( ) being presented at

🗓️ It will take place on Fri, Oct 7, 2022 6:00 PM - 7:00 PM BST

The iwAL meeting will cover several topics, including:
➡️ Novel treatment approaches in
➡️ the use of in clinical practice
➡️ Treating relapsed disease
➡️ The role of -T therapy
& MORE

Register here & don't miss it 👉 https://bit.ly/3K9mkD3

Featuring leading experts Sabina Chiaretti, Daniel DeAngelo, Nicholas Short, Dieter Hoelzer, Robin Foà & many more!

28/09/2022

Check out our Sessions 💬

This EXCLUSIVE discussion features leading experts Ruben Mesa, MD & Naveen Pemmaraju, MD who discuss key updates in the treatment and management of

They cover several topics, including advances in the treatment of essential ( ), vera ( ) and ( ), as well as ongoing clinical trials in the field & future outlooks💡

Give it a watch here 👉 https://www.vjhemonc.com/event/mpn-sessions-key-updates-from-the-2022-texas-mpn-workshop/

27/09/2022

“I think it's good to, once in a while, put out something that's purely for entertainment... Believe it or not, people actually tend to engage with that content MORE” - Sanam Loghavi 💭

This is a little snippet of a fantastic NEW VJSocial Masterclass coming SOON, all about Engagement on Twitter 📱

In this masterclass, Mohamad Mohty, Sanam Loghavi, Toby Eyre & Amer Zeidan share their own tips and advice on engaging on Twitter effectively and appropriately alongside your clinical practice - you won't want to miss it!

In the meantime, you can check out our previous VJSocial Masterclass with Naveen Pemmaraju, MD, Graham Collins & Aaron Gerds, MD, MS here 👉 https://bit.ly/3MBPk6I

23/09/2022

NEW episode on the 'Identifying high-risk and improving treatment strategies in these patients' 🎧

Multiple myeloma is a disease, and despite recent advances in therapeutic agents, several patients still relapse after therapy and have poor survival outcomes.

In this exclusive episode you'll hear from leading experts Heinz Ludwig, MD, Wilhelminen Cancer Research Institute & Meral Beksac, MD, Ankara University

They discuss:
➡️ Identifying high-risk myeloma patients
➡️ Parameters that can be used to define high-risk disease
➡️ Treatment strategies for this patient population, emphasizing the promise of CAR-T therapy and
& MORE

Give it a listen here 👉 https://www.vjhemonc.com/podcast/identifying-high-risk-myeloma-and-improving-treatment-strategies-in-these-patients/

The VJHemOnc Podcast covers latest news, trial updates, controversies and opinions in the & space

Remember to SUBSCRIBE so you don't miss any future episodes! 📱

Join us for an exclusive podcast with experts Heinz Ludwig and Meral Beksac, who discuss the identification of high-risk myeloma and treatment strategies.